Aptorum Group Limited - Kewajiban jangka dawa perusahaan APM

Simbol resmi perusahaan Aptorum Group Ltd (APM)

The development of new compounds at Aptorum Group Limited (APM) relies on collaboration with Hong Kong universities, although strict FDA oversight is slowing product launches. Stable raw material supply chains and secure delivery to clinics ensure uninterrupted research, with the indicator standing at 0.00. Securities price action on GURU.Markets reflects the impact of patents and breakthroughs in treating metabolic disorders.

APM Kewajiban jangka dawa perusahaan Aptorum Group Limited (04.07.2022 - 20.07.2026)
Produk seri aptorumgroup.com

For the long-term investor, the reliability of Aptorum Group Limited is determined by its ability to fund costly clinical developments without a critical increase in debt load. This indicator aggregates all obligations with a maturity of more than one year; therefore, analyzing the size of the firm's long-term borrowings allows for an assessment of credit risk and the financial stability of the business during the period of bringing new drugs to market.

Pesaing langsung

haleon.com - Silihan lan utang jangka dawa perusahaan|KVUE: Utang jangka dawa perusahaan|VRNA - Kewajiban jangka dawa perusahaan|MENS: Utang jangka dawa perusahaan|Utang jangka dawa perusahaan Ligand Corp|AMRX - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan PRGO|Alvotech SA - Utang jangka dawa perusahaan|Utang jangka dawa Liquidia Corp LQDA|Kewajiban jangka dawa perusahaan Galapagos Genomics (GLPG)|Gedhene kewajiban jangka dawa ANI Pharmaceuticals Corp ANIP|Utang jangka dawa perusahaan MannKind Corporation (MNKD)|AMPH - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan PCRX|SPRY (ARS Pharmaceuticals Inc) - Utang jangka dawa|TBPH - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan Aquestive Corp|Utang jangka dawa perusahaan SCPH|Utang jangka dawa perusahaan TECX (tectonictx.com)|Tonix Pharmaceuticals Holding Corp. (TNXP) - Utang jangka dawa perusahaan|SXTC - Kewajiban jangka dawa|Kewajiban jangka dawa perusahaan Eupraxia Pharma EPRX|BHST: Gedhene kewajiban jangka dawa|Utang jangka dawa perusahaan EXOZ|ORMP (Oramed Pharmaceuticals Inc.) - Utang jangka dawa|ENTX - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan MindWalk Holdings, Inc. (HYFT)|Kewajiban jangka dawa perusahaan ABVC|Utang jangka dawa perusahaan CPIX (Cumberland Corp)|Quantum BioPharma Ltd - Utang jangka dawa perusahaan|FGEN - Kewajiban jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Telomir Pharmaceuticals, Inc. (TELO)|RANI - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan SNYR (synergychc.com)|RLYB (Rallybio) - Tanggungan jangka dawa|LEXX - Utang jangka dawa perusahaan|Silihan lan utang jangka dawa perusahaan PULM|Pheton Holdings Ltd - Utang jangka dawa perusahaan|Utang jangka dawa Lyra Therapeutics Inc. LYRA|Kewajiban jangka dawa perusahaan IBO (Impact BioMedical Inc)|TNF Pharmaceuticals Inc. - Utang jangka dawa perusahaan|Utang jangka dawa perusahaan cbdMD Corp|painreform.com (PRFX) - Kewajiban jangka dawa|Kewajiban jangka dawa perusahaan altamiratherapeutics.com CYTO|LIPO (Lipella Pharmaceuticals Inc) - Silihan lan utang jangka dawa perusahaan|Utang jangka dawa perusahaan Optinose|Utang jangka dawa perusahaan Pieris Pharma|PROC (Procaps Group S.A.) - Utang jangka dawa perusahaan|Gunggunge utang jangka dawa PTPI (petrospharma.com)|Qilian International Holding - Utang jangka dawa perusahaan|Kewajiban jangka dawa perusahaan Acelyrin Inc. SLRN|Utang jangka dawa perusahaan TFFP (TFF Pharma)